HCW Biologics Inc. SEC filings HCWB
HCW Biologics Inc. has 340 filings in SEC EDGAR's recent list, going back to Oct 19, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (material agreement, unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1 | Registration statement | Oct 2, 2026 | — |
| S-1/A | Amended registration statement | Aug 28, 2026 | — |
| S-1 | Registration statement | Aug 20, 2026 | — |
| POS AM | Filing | Jul 16, 2026 | — |
| S-1/A | Amended registration statement | Jun 18, 2026 | — |
| S-1 | Registration statement | Jun 8, 2026 | — |
| POS AM | Filing | May 18, 2026 | — |
| POS AM | Filing | May 13, 2026 | — |
| S-1/A | Amended registration statement | Apr 24, 2026 | — |
| S-1 | Registration statement | Apr 23, 2026 | — |
| 424B4 | Prospectus | Feb 19, 2026 | — |
| S-1/A | Amended registration statement | Feb 17, 2026 | — |
| S-1/A | Amended registration statement | Feb 13, 2026 | — |
| S-1 | Registration statement | Feb 11, 2026 | — |
| S-1 | Registration statement | Jan 9, 2026 | — |
| 424B4 | Prospectus | May 15, 2025 | — |
| S-1/A | Amended registration statement | May 13, 2025 | — |
| S-1 | Registration statement | May 9, 2025 | — |
| 424B3 | Prospectus | Apr 16, 2025 | — |
| S-1 | Registration statement | Apr 7, 2025 | — |
| 424B2 | Prospectus | Nov 20, 2024 | — |
| S-3 | Shelf registration | Aug 19, 2022 | — |
| S-8 | Employee stock plan registration | Jul 21, 2021 | — |
| 424B4 | Prospectus | Jul 21, 2021 | — |
| S-1MEF | Filing | Jul 19, 2021 | — |
| FWP | Free writing prospectus | Jul 12, 2021 | — |
| S-1/A | Amended registration statement | Jul 9, 2021 | — |
| FWP | Free writing prospectus | Jul 7, 2021 | — |
| S-1/A | Amended registration statement | Jul 7, 2021 | — |
| S-1/A | Amended registration statement | Jun 15, 2021 | — |
| S-1 | Registration statement | May 26, 2021 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HCWB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miramar, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1828673
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.